What is IP Infusion?
Founded in 1999 and headquartered in Santa Clara, California, IP Infusion specializes in providing intelligent network software solutions designed to enhance IP services. The company operates globally, with additional locations in Japan, South Korea, India, China, and Germany, indicating a broad market reach and a commitment to serving diverse international clientele. Its focus on advanced network software positions it as a key player in the evolving telecommunications and enterprise networking landscape.
How much funding has IP Infusion raised?
IP Infusion has raised a total of $16.7M across 2 funding rounds:
Series B
$2M
Series C
$14.7M
Series B (2000): $2M with participation from Bill Tai, Yoshinari Yoshikawa, and IT-Farm
Series C (2002): $14.7M led by Bill Tai, Neoteny Labs, Yoshinari Yoshikawa, Formative Ventures, imGO, and Intel Capital
Key Investors in IP Infusion
Intel Capital
Intel Capital, a division of Intel, invests in innovative startups targeting artificial intelligence, autonomous vehicles, datacenter, Cloud, 5G, and next-generation compute. It is headquartered in Santa Clara, California.
Formative Ventures
Formative Ventures LLC operates in the Electronics industry, headquartered in Santa Clara, California, and focuses on early-stage technology investments.
Neoteny Labs
Neoteny Labs is an investment firm associated with Joichi Ito, focusing on technology and digital innovation, with a presence in Japan.
What's next for IP Infusion?
The company's history of enterprise-level funding, culminating in a recent major strategic investment, suggests a trajectory focused on scaling operations and further innovation in intelligent network solutions. This sustained financial support is indicative of strong investor confidence in IP Infusion's market position and future growth potential, likely enabling the company to expand its product offerings, enhance its technological capabilities, and solidify its competitive advantage in the global market.
See full IP Infusion company page
